WAM
DMAA

Wolverine Asset Management’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

Wolverine Asset Management’s Portfolio DMAA Stock Details DMAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.86M Sell
832,093
-721,615
-46% -$7.64M 0.08% 214
2026
Q1 		$16.3M Buy
1,553,708
+246,240
+19% +$2.57M 0.16% 138
2025
Q4 		$13.6M Buy
1,307,468
+58,340
+5% +$602K 0.11% 198
2025
Q3 		$12.8M Buy
1,249,128
+227,222
+22% +$2.33M 0.09% 206
2025
Q2 		$10.4M Buy
1,021,906
+418,868
+69% +$4.24M 0.1% 207
2025
Q1 		$6.04M Buy
+603,038
New +$6.03M 0.07% 270

Other funds holding DMAA

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.69% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.69% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.5% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.76B AUM 23.76% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
RC
RLH Capital Great Neck, New York $209M AUM

Wolverine Asset Management's DMAA Position: Q2 2026 in Review

Wolverine Asset Management reduced its Drugs Made In America Acquisition Corp (DMAA) stake by 46% in Q2 2026, selling an estimated $7.64M and leaving 832,093 shares worth $8.86M. The position accounts for 0.08% of the portfolio, ranked #214.

Wolverine Asset Management first reported a position in DMAA in Q1 2025 and has held it in 6 quarters since. The position peaked at $16.3M in Q1 2026. 18 funds tracked by Wall St. Rank hold DMAA as of Q2 2026.

  • Wolverine Asset Management held 832,093 shares of Drugs Made In America Acquisition Corp worth $8.86M as of Q2 2026.
  • Wolverine Asset Management sold 721,615 Drugs Made In America Acquisition Corp shares in Q2 2026, an estimated $7.64M.
  • Drugs Made In America Acquisition Corp made up 0.08% of Wolverine Asset Management's portfolio in Q2 2026, its #214 holding.
  • Wolverine Asset Management first reported a position in Drugs Made In America Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
  • Wolverine Asset Management's Drugs Made In America Acquisition Corp position peaked at $16.3M in Q1 2026.
  • 18 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.